In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers

Liver International

Volumn 25, Issue 2, 2005, Pages 357-366

  Hellerbrand, Claus ^a   Bataille, Frauke ^a   Schlegel, Jacqueline ^a   Hartmann, Arndt ^b   Mühlbauer, Marcus ^a   Schölmerich, Jürgen ^a   Büttner, Reinhard ^c   Hofstädter, Ferdinand ^a   Bosserhoff, Anja Katrin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Fibrosis; HCC; Hepatic stellate cells; Hepatitis C; Hepatocytes

Indexed keywords

ALPHA ACTIN; CELL MARKER; MELANOMA INHIBITORY ACTIVITY 2; MESSENGER RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL GRANULE; CELL MEMBRANE; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOPLASM; DATA ANALYSIS; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; STELLATE CELL; STROMA; TUMOR CELL LINE; UPREGULATION;

ADULT; BASE SEQUENCE; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS, CHRONIC; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROGNOSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TISSUE CULTURE TECHNIQUES;

EID: 17044403863     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01099.x     Document Type: Article

References (20)

1. Bosserhoff A K, Moser M, Schölmerich J, Buettner R, Hellerbrand C. Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes. J Biol Chem 2003; 278: 15225-31.
2. Bosserhoff A K, Buettner R. Expression, function and clinical relevance of MIA (melanoma inhibitory activity). Histol Histopathol 2002; 17: 289-300.
3. Stoll R, Renner C, Buettner R, Voelter W, Bosserhoff A K, Holak T A. Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains. Protein Sci 2003; 12: 510-9.
4. Stoll R, Renner C, Zweckstetter M, Bruggert M, Ambrosius D, Palme S, Engh R A, Golob M, Breibach I, Buettner R, Voelter W, Holak T A, Bosserhoff A K. The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold. EMBO J 2001; 20: 340-9.
5. Safadi R, Friedman S L. Hepatic fibrosis - role of hepatic stellate cell activation. Med Gen Med 2002; 4: 27.
6. Hautekeete M L, Geerts A. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch 1997; 430: 195-207.
7. Cassiman D, Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J Hepatol 2002; 37: 527-35.
8. Ramadori G, Saile B. Mesenchymal cells in the liver - one cell type or two? Liver 2002; 22: 283-94.
9. Marra F. Hepatic stellate cells and the regulation of liver inflammation. J Hepatol 1999; 31: 1120-30.
10. Weiss T S, Jahn B, Cetto M, Jauch K W, Thasler W E. Collagen sandwich culture affects intracellular polyamine levels of human hepatocytes. Cell Prolif 2002; 35: 257-67.
11. Desmet V J, Gerber M, Hoofnagle J H, Manns M, Scheuer P J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
12. International Union Against Cancer TNM classification of malignant tumors. Berlin: Springer-Verlag, 2002.
13. Edmondson H A, Steiner P E. Primary carcinoma of the liver: a study of 100 cases among 48.900 necropsies. Cancer 1954; 7: 462-504.
14. Kononen J, Bubendorf L, Kollioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch M J, Sauter G, Kallioniemi O P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-7.
15. Remmele W, Stegner H E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987; 8: 138-40.
16. Ooi L P, Crawford D H, Gotley D C, Clouston A D, Strong R W, Gobe G C, Halliday J W, Bridle K R, Ramm GA. Evidence that 'myofibroblast-like' cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol 1997; 26: 798-807.
17. Faouzi S, Lepreux S, Bedin C, Dubuisson L, Balabaud C, Bioulac-Sage P, Desmouliere A, Rosenbaum J. Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest 1999; 79: 485-93.
18. Ooi L L, Bay B H, Ng R T, Song I C, Mack P O. An animal model for the study of hepatic stellate cell and hepatocellular carcinoma interaction. Ann Acad Med Singapore 1999; 28: 95-8.
19. Ballardini G, Degli E S, Bianchi F B, de Giorgi L B, Faccani A, Biolchini L, Busachi C A, Pisi E. Correlation between Ito cells and fibrogenesis in an experimental model of hepatic fibrosis. A sequential stereological study. Liver 1983; 3: 58-63.
20. Knittel T, Kobold D, Piscaglia F, Saile B, Neubauer K, Mehde M, Timpl R, Ramadori G. Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast sub-populations in hepatic tissue repair. Histochem Cell Biol 1999; 112: 387-401.